Criticalkare Pharma

Treatment Type	Relapsed or refractory multiple myeloma
Dosage Form	Injection
Brand	JOHNSON & JOHNSON PVT LTD
Composition	Teclistamab
Manufacturer	JOHNSON & JOHNSON PVT LTD
Strength	30mg
Packaging Size	1 unit
Storage	2-8 degree c
Packing Type	Vial
Shelf Life	24 months

Tecvayli 30mg Injection contains the active substance Teclistamab. It is an anticancer medication classified as a bispecific monoclonal antibody. Tecvayli 30mg Injection is used for the treatment of adult patients with relapsed or refractory multiple myeloma, a type of cancer affecting plasma cells in the bone marrow, who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody. Tecvayli works by targeting and binding to both B-cell maturation antigen (BCMA) on myeloma cells and CD3 on T cells. This dual binding activates T cells to recognise and destroy the BCMA-expressing myeloma cells.
Inform your doctor before starting treatment with Tecvayli 30mg Injection, as it may lead to serious side effects such as cytokine release syndrome (CRS), neurotoxicities, and infections. Regular monitoring and prompt management of these conditions are crucial during therapy. Make sure to inform your physician of all the medicines you are taking before starting treatment with Tecvayli 30mg Injection. Report any symptoms such as difficulty breathing, cough, fever, chest pain, weakness, or seizures to your doctor.
UsesTo treat adult patients with relapsed or refractory multiple myeloma (a type of cancer affecting plasma cells in the bone marrow) who have previously received at least four lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody.
Storage
Store Tecvayli 30mg Injection in the refrigerator at 2°C to 8°C. Do not freeze.Keep out of sight and reach of children and pets.Store in the original container to protect from light.Monitor patients regularly for signs and symptoms of cytokine release syndrome (CRS) and neurological toxicities.Regular blood tests should be conducted to detect any abnormalities and other potential side effects, as directed by the healthcare provider.
Side Effects
Common:Cytokine release syndrome (fever, chills, nausea, fatigue)Neurological symptoms (headache, dizziness)FatigueInjection site reactions Rare:Severe neurological symptoms (confusion, seizures)Difficulty breathing or swallowingSwelling of the face, lips, or tongueHigh feverSkin rash or severe skin reactionsRapid heartbeat

Treatment Type	Relapsed or refractory multiple myeloma
Dosage Form	Injection
Brand	JOHNSON & JOHNSON PVT LTD
Composition	Teclistamab 153mg
Manufacturer	JOHNSON & JOHNSON PVT LTD
Strength	153 mg
Packaging Size	1 unit
Storage	2-8 degree c
Packing Type	Vial
Shelf Life	24 months

Tecvayli 153mg Injection contains the active substance Teclistamab. It is an anticancer medication classified as a bispecific monoclonal antibody.
Tecvayli Injection is used for the treatment of adult patients with relapsed or refractory multiple myeloma, a type of cancer affecting plasma cells in the bone marrow, who have received at least four prior lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody.
Tecvayli works by targeting and binding to both B-cell maturation antigen (BCMA) on myeloma cells and CD3 on T cells. This dual binding activates T cells to recognise and destroy the BCMA-expressing myeloma cells.
Inform your doctor before starting treatment with Tecvayli 153mg Injection, as it may lead to serious side effects such as cytokine release syndrome (CRS), neurotoxicities, and infections. Regular monitoring and prompt management of these conditions are crucial during therapy.
Make sure to inform your physician of all the medicines you are taking before starting treatment with Tecvayli 153mg Injection. Report any symptoms such as difficulty breathing, cough, fever, chest pain, weakness, or seizures to your doctor.
UsesTo treat adult patients with relapsed or refractory multiple myeloma (a type of cancer affecting plasma cells in the bone marrow) who have previously received at least four lines of therapy, including a proteasome inhibitor, an immunomodulatory agent, and an anti-CD38 antibody.
Storage
Store Tecvayli 153mg Injection in the refrigerator at 2°C to 8°C. Do not freeze.Keep out of sight and reach of children and pets.Store in the original container to protect from light.Monitor patients regularly for signs and symptoms of cytokine release syndrome (CRS) and neurological toxicities.Conduct regular blood tests to detect any abnormalities and other potential side effects, as directed by the healthcare provider.
Side Effects
Common:Cytokine release syndrome (fever, chills, nausea, fatigue)Neurological symptoms (headache, dizziness)FatigueInjection site reactions Rare:Severe neurological symptoms (confusion, seizures)Difficulty breathing or swallowingSwelling of the face, lips, or tongueHigh feverSkin rash or severe skin reactionsRapid heartbeat

Formulation Type	Nanoparticle Albumin-Bound
Brand	AB Taxomed
Pharmacopoeia Standard	IP
Strength	100 mg
Packaging Size	20ml
Shelf Life	24 months
Brand Name	Ab-Taxomed 100mg Injection
Manufacturer	Medicamen Biotech Ltd
Usages	used for the treatment of breast cancer, pancreatic cancer and non-small cell lung cancer in adults
Country of Origin	Made in India
Packaging Type	Box
Pack Type	Vial

AB-Taxomed 100 mg Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count.

This injection is not recommended for adolescents and children under the age of 18. Talk to your doctor if you have heart disorders before taking this medicine. Administration of this medicine can cause serious allergic reactions. Use effective birth control during the treatment and for at least six months after the last dose. This Injection may harm patients suffering from alcoholism as this medicine contains alcohol.

Uses of Ab-taxomed 100mg Injection

• Ovarian cancer
• Breast cancer
• Non-small cell lung cancer
• AIDS-related Kaposi’s sarcoma

Therapeutic Effects of Ab-taxomed 100mg Injection

AB-Taxomed 100 mg Injection binds to β-tubulin subunits of microtubules, interferes with interphase (a process involving cell growth) and mitotic functions (a process of cell division), and prevents the growth of cancer cells.

Interaction of Ab-taxomed 100mg Injection with other drugs

Inform your doctor about any prescribed medicines, over-the-counter medications, nutritional and vitamin supplements, or herbal products that you are taking or have taken before the treatment. Certain medications may interact with AB-Taxomed 100 mg injection and cause undesirable side effects.

More Information

• Keep AB-Taxomed 100 mg Injection out of sight and reach of children.
• Do not store above 25°C.

Safety Advices   Pregnancy  

AB-Taxomed 100 mg Injection can harm your unborn baby. Tell your doctor if you are pregnant or planning to get pregnant before taking this Injection.   

Breast Feeding  

Stop breastfeeding during the treatment with AB-Taxomed 100 mg Injection. Consult your doctor for potential risks.  

Lungs  

It is unknown whether AB-Taxomed 100 mg injection can be given to patients with lung disorders. Please consult your physician for more advice.  

Liver  

It is contraindicated in patients with severe liver disorders. Inform your doctor if you have any liver disorders before taking AB-Taxomed 100 mg Injection.  

Alcohol  

It is unsafe to consume alcohol with AB-Taxomed 100 mg Injection.  

Driving

The alcohol present in AB-Taxomed 100 mg Injection may affect your ability to drive. Avoid driving if you feel unwell.

Side Effects

• Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)
• Severe diarrhea
• Severe stomach pain

• Anemia, feeling tired
• Hair loss
• Burning, tingling, or numbness in your feet or hands
• Muscle and joint pain
• Vomiting, nausea
• Mouth or lip sores
• Infections
• Swelling of hands, feet, and face
• Bleeding
• Irritation at the injection site
• Low blood pressure

Dose Strength	40
Strength	40 mg
Packaging Size	40 mg/ml
Dosage Form	Solution for Injection
Packaging Type	Vial
Brand	Opdyta
Treatment	Melanoma
Package Type	Vial
Storage	2-8 degree c
Shelf Life	24 month
Usage	Hospital
Composition	Nivolumab
Country of Origin	Made in India

Opdyta 40mg Injection consists of the active substance Nivolumab. It is indicated to treat cancers of the skin, lungs, kidney, lymph node, bladder, esophagus, and urinary tract. This medicine is indicated when the cancer has recurred after treatment using medicines, surgery, and radiation. It is a medication that helps the immune system fight cancer more effectively. It works by targeting and inhibiting specific molecules that can suppress or weaken the immune system's ability to recognize and attack cancer cells. By blocking these molecules, it helps to enhance the immune response against cancer and potentially shrink or slow the growth of tumors.

Uses

• Advanced skin cancer
• Skin cancer that recurs after surgery
• Advanced non-small cell lung cancer
• Advanced kidney cancer
• Hodgkin’s lymphoma (lymph node disease)
• Advanced cancer of the head and neck
• Advanced urinary tract and bladder cancer
• Advanced esophageal cancer

More Information

• Opdyta 40mg Injection is typically supplied in vials or pre-filled syringes and should be stored at controlled room temperature between 20-25°C (68-77°F).
• The drug should be protected from light and should not be frozen.
• Once the vial or syringe is opened, any unused portion should be discarded. It is important to follow the manufacturer's instructions for handling and storage of it to ensure that the drug is effective and safe for use.
• Keep it out of reach from children and pets.

Safety Advices Pregnancy

Opdyta 40mg Injection is unsafe for a developing foetus and is not recommended during pregnancy as it can cause harm to the developing foetus.  

Breast Feeding

It is unknown whether Opdyta 40mg Injection is excreted in human breast milk, so breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.

 Lungs

Opdyta 40mg Injection should be used cautiously in individuals with lung disease, as the medication can potentially worsen lung function. Your healthcare provider will monitor you closely if you have lung disease and adjust your dosage if necessary. If you have lung disease or a history of respiratory problems, discussing the potential risks and benefits of the injection treatment with your healthcare provider is important. Your healthcare provider may recommend additional monitoring or testing to ensure the medication is not causing any adverse effects on your lungs.  
Liver

Opdyta 40mg Injection should be used cautiously in individuals with liver disease, as the medication is primarily metabolized in the liver and could potentially worsen liver function. Your healthcare provider will monitor you closely if you have liver disease and adjust your dosage if necessary.   

Alcohol

There are no known interactions between Opdyta 40mg Injection and alcohol. However, it is generally recommended to avoid consuming alcohol while being treated for a medical condition, as alcohol can potentially interfere with the effectiveness of the medication and increase the risk of side effects.  

Driving

Patients receiving Opdyta 40mg Injection should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.

Side Effects

• Pneumonitis (inflammation of lung tissue)
• Colitis (inflammation of the colon)
• Hepatitis (inflammation of the liver)
• Hypothyroidism
• Hyperthyroidism
• Adrenal insufficiency (a condition in which the adrenal glands do not produce enough hormones).
• Severe allergic reactions
• Infusion-related reactions

Additional Information:

• Production Capacity: 100
• Delivery Time: 72 working hours
• Packaging Details: 1 vial of 4ml

Dose Strength	100
Strength	100 mg
Packaging Size	10 mg/ml
Dosage Form	Injection
Packaging Type	Vial
Brand	Opdyta
Treatment	Bladder Cancer
Package Type	Vial
Country of Origin	Made in India

Opdyta 100mg Injection consists of the active substance Nivolumab. It is indicated to treat cancers of the skin, lungs, kidney, lymph node, bladder, esophagus, and urinary tract. This medicine is indicated when the cancer has recurred after treatment using medicines, surgery, and radiation. It is a medication that helps the immune system fight cancer more effectively. It works by targeting and inhibiting specific molecules that can suppress or weaken the immune system's ability to recognize and attack cancer cells. By blocking these molecules, it helps to enhance the immune response against cancer and potentially shrink or slow the growth of tumors.

Uses

• Advanced skin cancer
• Skin cancer that recurs after surgery
• Advanced non-small cell lung cancer
• Advanced kidney cancer
• Hodgkin’s lymphoma (lymph node disease)
• Advanced cancer of the head and neck
• Advanced urinary tract and bladder cancer
• Advanced esophageal cancer

More Information

• Opdyta 100mg Injection is typically supplied in vials or pre-filled syringes and should be stored at controlled room temperature between 20-25°C (68-77°F).
• The drug should be protected from light and should not be frozen.
• Once the vial or syringe is opened, any unused portion should be discarded. It is important to follow the manufacturer's instructions for handling and storage of it to ensure that the drug is effective and safe for use.
• Keep it out of reach from children and pets.

Safety Advices Pregnancy

Opdyta 100mg Injection is unsafe for a developing foetus and is not recommended during pregnancy as it can cause harm to the developing foetus.  

Breast Feeding

It is unknown whether Opdyta 100mg Injection is excreted in human breast milk, so breastfeeding women should discuss the potential risks and benefits of the medication with their healthcare provider before starting treatment.  

Lungs

Opdyta 100mg Injection should be used cautiously in individuals with lung disease, as the medication can potentially worsen lung function. Your healthcare provider will monitor you closely if you have lung disease and adjust your dosage if necessary. If you have lung disease or a history of respiratory problems, discussing the potential risks and benefits of the injection treatment with your healthcare provider is important. Your healthcare provider may recommend additional monitoring or testing to ensure the medication is not causing any adverse effects on your lungs.  

Liver

Opdyta 100mg Injection should be used cautiously in individuals with liver disease, as the medication is primarily metabolized in the liver and could potentially worsen liver function. Your healthcare provider will monitor you closely if you have liver disease and adjust your dosage if necessary.  

Alcohol

There are no known interactions between Opdyta 100mg Injection and alcohol. However, it is generally recommended to avoid consuming alcohol while being treated for a medical condition, as alcohol can potentially interfere with the effectiveness of the medication and increase the risk of side effects.  

Driving

Patients receiving Opdyta 100mg Injection should be advised to avoid driving or operating machinery if they experience side effects such as fatigue, dizziness, or blurred vision, impairing a patient's ability to drive or operate machinery safely.

Side Effects

• Pneumonitis (inflammation of lung tissue)
• Colitis (inflammation of the colon)
• Hepatitis (inflammation of the liver)
• Hypothyroidism
• Hyperthyroidism
• Adrenal insufficiency (a condition in which the adrenal glands do not produce enough hormones).
• Severe allergic reactions
• Infusion-related reactions

Manufacturer	Natco Pharma
Packaging Size	1 vial
Volume	250mg/ml
Treatment	Advanced Breast Cancer
Packaging Type	Vial
Strength	250 mg
Packing	1 Vial
Physical Form	Solution
Storage Condition	Refrigerated 2 to 8 degree c
Shelf Life	24 months
Application	It should only be administered by a trained doctor or nurse as a slow intramuscular injection. Do no
Manufactured By	NATCO PHARMA LTD
Brand	Fulvenat
Country of Origin	Made in India

Fulvenat 250mg injection contains the active substance fulvestrant. It is an antineoplastic drug that belongs to the class estrogen receptor antagonist. Estrogen, a type of female sex hormone, can sometimes be involved in the growth of breast cancer. This medicine is used alone to treat postmenopausal women with a certain type of breast cancer called estrogen receptor-positive breast cancer that is locally advanced or spread to other parts of the body. It is also indicated in combination with other anti-cancer medication to treat women with certain types of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, which is locally advanced or spread to other parts of the body.

UsesTreat Hormone receptor (HR)-positive, human epidermal growth receptor 2 (HER2)-negative breast cancer in postmenopausal women.

Store Fulvenat 250mg injection in the refrigerator (2°C to 8°C)Do not freezekeep the injection away from the reach of children and pets.If you have missed any dosing appointments, inform your doctor and schedule immediately.

Constipation, diarrheaLoss of appetiteNausea, vomitingDecreased RBC, WBC, and PlateletsInfectionsJoint and muscle painBackache, bone painWeakness, tirednessHeadacheCough, difficulty breathingHot flushesPain at the site of injectionChanges in heart rhythmSevere neutropenia(decreased WBC)Liver failure, inflammation of liverHypersensitivity reactionSwelling in the body

Dosage Form	Injection
Strength	100 mg
Treatment	Acute Myeloid Leukemia
Manufacturer	Sun Pharmaceutical
Packaging Size	100 ml
Dose Strength	100 mg
Storage Condition	Do Not Freeze
Country of Origin	Made in India

Azadine 100mg Injection for injection is used for treating adults with Myelodysplastic syndrome (MDS) and Acute myeloid leukemia (AML) if they are considered ineligible for stem cell transplant. In Myelodysplastic Syndrome, the bone marrow does not produce healthy blood cells due to its lack of function. Acute Myeloid Leukemia is a type of bone marrow cancer that is caused by the release of incompletely formed blood cells into the bloodstream.

UsesTreatment of Acute Myeloid Leukemia with 20-30% blasts in patients who are not eligible for Haemopoietic stem cell transplantIntermediate-2 and High-risk Myelodysplastic syndrome (MDS)

Storage
Store at room temperature (15-30°C). If the product is reconstituted, it must be used immediately; if not, store at 2-8°C for not more than 8 hours. Keep the injection out of sight and reach of children.

Side Effects
Unexpected bleeding, with blood in stool and urineFeverPneumonia, is characterized by chest pain or breathlessness.Allergic reaction with symptoms of swelling of lips, itching, or rashes.Seizures, loss of consciousness, severe headache, or bleeding in the brainFrequent urination with pain or burning sensation Disturbances in the blood count (RBC, WBC, Platelets)Nausea, vomiting, diarrheaConstipationTirednessSkin reactions like redness and pain at the site of injectionDecreased appetiteDizzinessPain in extremitiesJoint painStomach painHeadacheSore nose and throatRashes and bruising

Treatment	Hormone Receptor Positive Breast Cancer
Manufacturer	Natco Pharma
Packaging Size	1 vial
Packaging Type	Vial
Strength	250 mg
Storage Condition	Cool Dry Place
Shelf Life	24 months

Fulvenat 250mg injection contains the active substance fulvestrant. It is an antineoplastic drug that belongs to the class estrogen receptor antagonist. Estrogen, a type of female sex hormone, can sometimes be involved in the growth of breast cancer. This medicine is used alone to treat postmenopausal women with a certain type of breast cancer called estrogen receptor-positive breast cancer that is locally advanced or spread to other parts of the body. It is also indicated in combination with other anti-cancer medication to treat women with certain types of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer, which is locally advanced or spread to other parts of the body. 
Do not take this injection if you are allergic to fulvestrant or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver problems. Before initiating the treatment, inform your physician if you have kidney or liver problems, bone diseases, bleeding disorders, and heart diseases. Fulvenat 250mg injection is not indicated in children and adolescents under 18 years. Report to your physician if you have allergic reactions, including swelling of the face, lips, tongue, or throat, after administering this injection.

Formulation Type	Solution
Form of Medicine	Liquid
Brand	Docetere
Strength	20 mg
Pack Type	Vial
Indication	Head And Neck Cancer
Packaging Type	Vial
Brand Name	Docetere
Manufacturer	DR REDDY'S LABORATORIES LTD
Usages	To treat breast, prostate, non-small cell lung, stomach, and head and neck cancer.
Country of Origin	Made in India
Pack Size	0.5 ml
Packaging Size	2 ml

Docetere 20mg Injection belongs to the class of anticancer medications known as taxoids. It contains the active constituent Docetaxel indicated to treat breast, prostate, non-small cell lung, stomach, and head and neck cancer. Cancer is a disease in which cells multiply in an uncontrolled and abnormal manner. This chemotherapy medication is used alone or in combination with other anticancer medicines.   
The common side effects that are likely to be associated with Docetere 20mg Injection are dizziness, headache, fever, infections, loss of appetite, sleeping trouble, joint or muscle pain, eye problems, weight loss, tiredness, dry mouth, reduced blood pressure, hair loss, etc. Inform your doctor if any of these side effects disturb or persist in you. 

Uses
Non-small cell lung cancerBreast cancerStomach or gastric cancerProstate cancerHead and neck cancer

Storage
Do not store above 25°C.

Side Effects
Severe allergic reactionsSevere fluid retentionSevere skin problemsSwelling of the small intestine and colonHeadache, dizzinessFever, infectionsLow blood cell countLoss of appetiteTrouble sleepingJoint or muscle painAlteration in the sense of tasteEye problems, bleeding from the noseNausea, vomitingDiarrhea, constipationAbdominal painHair loss, change in color of your nailsChange or absence of menstrual periodWeight lossTirednessDry mouthHigh blood sugarDecreased blood pressure, rapid heartbeat

Treatment	Myelodysplastic Syndrome
Dosage Form	Lyophilized Powder for Injection
Strength	50 mg
Packaging Type	Vial
Physical Form	Lyophilized
Brand	Natdecita
Manufacturer	Natco Pharma
Country of Origin	Made in India

Natdecita 50mg injection contains the active substance decitabine. It is an antineoplastic drug that belongs to the class of medications called DNA methylation inhibitors. It is used to treat myelodysplastic syndrome (a group of conditions in which the bone marrow produces blood cells that are misshapen and do not produce enough healthy blood cells). It is also used to treat a type of cancer called acute myeloid leukemia (AML). It works by stopping the cancer cells from growing.  
Do not take this injection if you are allergic to Natdecita 50mg injection or any other ingredients of this medicine. Inform your physician if you have an infection, decreased blood cell count, liver disease, kidney disorder, and a heart disorder. This medicine is not recommended for children or young people below 18 years of age. This medicine can cause a serious immune reaction called differentiation syndrome. Report to your physician if you face any symptoms of sudden difficulty in breathing, cough, fever, or swelling in the body.

Uses
Myelodysplastic syndromes (MDS)Acute myeloid leukemia (AML)

Storage
Do not store it above 25°C

Side Effects
Swelling in the face, hands, and feetSwelling and pain in the skinDiscoloration of the skinIncreased blood sugar levelsDecreased albumin levelsAbdominal pain, constipationDecrease in appetiteDiarrhea, indigestionNausea, vomitingInsomina, dizzinessPain in limbsHeart problemsAnemiaInfectionBleedingFluid in the lungsPneumonia

Formulation Type	Nanoparticle Albumin-Bound
Brand	Paclitax-NAB
Pharmacopoeia Standard	IP
Strength	100 mg
Pack Type	Vial
Shelf Life	24 months
Packaging Type	Vial
Brand Name	Paclitax NAB
Manufacturer	CIPLA LTD
Usages	Ovarian cancer Breast cancer Non-small cell lung cancer AIDS-related Kaposi's sarcoma
Country of Origin	Made in India
Pack Size	50 ml
Packaging Size	16.7 ml

Paclitax Nab Injection is an anticancer medicine. It treats breast cancer, non-small cell lung cancer, ovarian cancer, and AIDS (Acquired Immuno-Deficiency Syndrome). Cancer is a condition in which cells are dividing and growing fast and in an uncontrolled manner. This Injection may be given alone or in combination with other anticancer medicines. It should not be used for severe liver problems, uncontrolled infection, and low white blood cell or platelet count.

Uses
Ovarian cancerBreast cancerNon-small cell lung cancerAIDS-related Kaposi’s sarcoma

Storage
Do not store above 25°C.

Side Effecst 
Serious allergic reactions (rash, swelling of face, lips, throat, or tongue, trouble breathing, and swallowing)Severe diarrheaSevere stomach painAnemia, feeling tiredHair lossBurning, tingling, or numbness in your feet or handsMuscle and joint painVomiting, nauseaMouth or lip soresInfectionsSwelling of hands, feet, and faceBleedingIrritation at the injection siteLow blood pressure

Brand	Remicade
Strength	100 mg
Route	IV Infusion
Drug Strength	100 mg
Pack Type	Vial
Brand Name	Remicade
Pack Type	Vial
Manufacturer	Janssen
Usage	Ankylosing Spondylitis, Ulcerative Colitis, Psoriatic Arthritis, Rheumatoid Arthritis
Originator Or Biosimilar	Originator
Composition	Infliximab 100mg
Packaging Size	1's
Usages	Rheumatoid arthritis Psoriatic arthritis Ankylosing spondylitis Psoriasis Crohn's disease Ulcerative
Shelf Life	24 months
Prescription Type	Prescription
Also Gives	PCD Pharma Franchise

Remicade 100mg Injection is an antirheumatic medication that belongs to a class of drugs known as TNF (tumour necrosis factor) alfa inhibitors containing the active ingredient Infliximab. This medication is used to treat various inflammatory conditions, primarily autoimmune diseases like rheumatoid arthritis, Crohn's disease, ulcerative colitis, ankylosing spondylitis, psoriatic arthritis, and psoriasis.

Uses
Rheumatoid arthritisPsoriatic arthritisAnkylosing spondylitisPsoriasisCrohn’s diseaseUlcerative colitis

Storage
Store Remicade 100mg Injection in a refrigerator at (2°C to 8°C).Do not freeze.

Side Effects
Serious infections (TB, blood infections, fungal infections)Low blood countsPossible signs of cancer (weight loss, fever, changes in moles or skin coloring, unusual vaginal bleeding)Upper respiratory infectionsInjection site reactionsHeadache, dizzinessStomach pain, pain in joints, muscles or backDifficulty breathing, chest painDiarrhea, constipationIndigestion, heartburnBruising, flushing, nosebleedFeeling tiredDepression, difficulty sleepingEye problemsFast heart beatHair lossTingling sensation or numbness

Strength	10.8 mg
Dose Schedule	Monthly
Brand	Zoladex LA
Route	SC
Form	Injection
Usage	Cancer Care, Breast Cancer, Endometriosis, Prostate Cancer
Packaging Type	Box
Storage Condition	Store Zoladex LA 10.8mg injection in the original package at room temperature ( Do not exceed 25 DegreeC)
Manufacturer	ASTRAZENECA PHARMA INDIA LTD
Prescription/Non prescription	Prescription
Shelf Life	24 months
Country of Origin	Made in India

Zoladex LA 10.8mg injection, containing Goserelin Acetate, is an LHRH agonist used in chemotherapy. For men, it treats localized and advanced prostate cancer, both alone and with other drugs. Women use it for advanced breast cancer, endometriosis, uterine fibroids, and as a pre-surgery endometrial thinner. It also assists in treating infertility when combined with other medications.

Uses
In men, it is used in combination with other medications to treat prostate cancer, while in women, it treats advanced breast cancer.Used to treat endometriosis (A disorder in which tissue that normally lines the uterus grows outside the uterus) and uterine fibroids.Serves as an endometrial-thinning agent prior to uterine surgery and aids in treating infertility in women when used with other medications.

Storage
Store Zoladex LA 10.8mg injection in the original package at room temperature ( Do not exceed 25°C)

Side Effects
AcneHot flushes and SweatingSwelling in the hands and legsHeadacheDepression and mood swingsErectile dysfunctionSexual dysfunctionPain, bruising, and bleedingPain while urinating ( in men)Dryness or itching of the vaginaThinning of bonesIncreased blood pressureIncreased risk of Heart failureIncreased risk of DiabetesIncreased risk of strokeInjection site injurySevere skin reactions

Strength	2 mg
Dose/Strength	2 mg
Brand	Bortenat
Pack Size	Vial
Form	Injection
Route	SC
Usage	Lymphoma, Multiple Myeloma, Cancer Care
Packaging Type	Vial
Storage Condition	Store unopened vials in the refrigerator (2 DegreeC - 8 DegreeC) and protect them from light.
Manufactured By	NATCO PHARMA LTD
Prescription/Non prescription	Prescription
Usage/Application	Hospital
Shelf life	24 months
Country of Origin	Made in India

Bortenat 2mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant.

Uses
Treatment of multiple myeloma and mantle cell lymphoma.

Storage
Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.

Side Effects 
Muscle crampsConfusion, visual disturbances, seizures, and headacheBreathlessnessSwelling of feetChanges in heartbeatHigh blood pressureFainting and tirednessCough and chest tightnessPneumoniaLoss of appetiteSensitivity, tingling and burning sensation of the skinNausea, vomiting, and diarrheaMouth ulcersConstipationMuscle and bone painHair lossFeverReduction in blood cell countReduced kidney functionShiveringInfectionsItching and rednessDehydrationStomach problemsDifficulty sleeping, anxiety, mood swings, depressed mood

Strength	3.5 mg
Volume Per Vial	3.5mg/ml
Route Of Administration	Subcutaneous
Packaging Type	Vial
Manufacturer	Natco Pharma Ltd
Reconstitution Required	No
Shelf Life	2 year
Country of Origin	Made in India

Bortenat 3.5mg Injection is a chemotherapy medication that belongs to the class of medicines called proteasome inhibitors. It consists of the active ingredient Bortezomib. It is indicated for the treatment of multiple myeloma and mantle cell lymphoma. Multiple myeloma refers to the cancerous progression of plasma cells that are predominant in the bone marrow. Mantle cell lymphoma is a less common cancer affecting the lymph nodes. This medication is concomitantly used with other chemotherapy medicines like pegylated liposomal doxorubicin, rituximab, cyclophosphamide, doxorubicin, dexamethasone, prednisolone or thalidomide for patients who have not started treatment and are ineligible for blood stem cell transplant.

Uses
Treatment of multiple myeloma and mantle cell lymphoma.

Storage
Store unopened vials in the refrigerator (2 °C – 8 °C) and protect them from light.

Side Effects 
Muscle crampsConfusion, visual disturbances, seizures, and headacheBreathlessnessSwelling of feetChanges in heartbeatHigh blood pressureFainting and tirednessCough and chest tightnessPneumoniaLoss of appetiteSensitivity, tingling and burning sensation of the skinNausea, vomiting, and diarrheaMouth ulcersConstipationMuscle and bone painHair lossFeverReduction in blood cell countReduced kidney functionShiveringInfectionsItching and rednessDehydrationStomach problemsDifficulty sleeping, anxiety, mood swings, depressed mood

Treatment	Multiple Myeloma
Treatment Type	Multiple Myleoma
Brand	Natco
Manufacturer	Natco Pharma
Packaging Type	Vial
Dosage Form	Injection
Strength	60 mg
Storage Temperature	2-8 degree c
Form	Injection
Storage Condition	stored under refrigeration between 2 DegreeC to 8 DegreeC (36 DegreeF to 46 DegreeF)
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Carfilnat 60mg Injection is an anticancer medication containing the active constituent Carfilzomib. It is used to treat a type of cancer called multiple myeloma. Multiple myeloma is a cancer of a white blood cell called the plasma cell. These cells grow uncontrolled and accumulate in the bone marrow, damaging the bones and kidneys. The treatment with this medication reduces symptoms of multiple myelomas, such as bone pain, fatigue, and anemia, improving a patient's quality of life.

Uses
Treatment of multiple myeloma

Storage
Carfilnat 60mg Injection should be stored under refrigeration between 2°C to 8°C (36°F to 46°F).Keep it in the original package until it is ready to use.Should not be frozen.

Side Effects
Cardiac events such as heart failure, heart attack, or arrhythmiasBlood clotting disorders or bleedingAcute kidney injuryLung damage or inflammationInfectionsTumor lysis syndrome (a condition that can occur when cancer cells break down rapidly)FatigueNausea and vomitingDiarrheaLow blood cell counts (anemia, low white blood cell count, low platelet count)FeverHeadacheDifficulty breathing or shortness of breathCoughMuscle weakness or painRashBack pain

Dose	60 mg
Treatment Type	Advanced Prostrate Cancer
Dosage Form	Injection
Treatment	Prostate Cancer
Packaging Type	Vial
Route of Administration	Intravenous
Concentration	40 mg/ml
Country of Origin	Made in India
Brand	Kabanat
Manufacturer	NATCO PHARMA LTD
Salt Composition	Cabazitaxel 60mg

Kabanat 60mg Injection contains the active constituent cabazitaxel. It is an anticancer medicine used with steroid medicine prednisone or prednisolone to treat people with hormone-refractory metastatic prostate cancer that has progressed after treatment with other anticancer medications, including docetaxel. Cancer is an abnormal and uncontrolled multiplication of cells. Many early-stage prostate cancers need normal testosterone (male hormone) levels to grow. In hormone-refractory metastatic prostate cancer, cancer keeps growing even when the amount of testosterone in the body is reduced to low levels. This medicine should not be used if you have a severe abnormal liver function or have recently been vaccinated against yellow fever. 
Its major toxicities include myelosuppression, neurotoxicity, and allergic reactions. Neutropenia is the most common adverse reaction to this drug. Monitoring of complete blood counts is essential on a weekly basis during cycle 1 and before each treatment cycle thereafter so that the dose can be adjusted if needed. Vaccination with a live attenuated vaccine should be avoided in patients receiving the medicine, instead killed or inactivated vaccines can be administered.

Uses
Advanced prostate cancer.

Storage
Store Kabanat 60mg injection in the original package at room temperature (30°C).

Side Effects
Low white blood cellsInfection (fever, cough, muscle aches, burning on urination)Severe allergic reactions (rash, itching, breathing problems, swelling of face, chest, or throat tightness)Kidney damageSevere stomach painLow red blood cell countLow blood platelet countConstipationBack pain, joint painDecreased appetiteHair lossNumbness, burning, tingling, or decreased sensation in your feet or handsTaste changeHeadache, dizzinessInflammation of the mouthBlood in urine

Strength	100 mg
Active Ingredient	Bevacizumab
Pharmaceutical Form	Injectable Solution
Volume	4 ml
Packaging Type	Vial
Country of Origin	Made in India
Brand	Abevmy
Manufacturer	MYLAN PHARMACEUTICALS PVT LTD
Generic Name	Bevacizumab

Abevmy 100mg Injection is an anticancer medicine consisting of the active ingredient Bevacizumab. This medicine is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Abevmy 100mg Injection is not recommended for adolescents and children under the age of 18. Discuss with your doctor about the preservation of ovaries if you are planning for pregnancy in the near future as this medicine may cause fertility issues in women. It would be best to avoid breastfeeding your baby as this medicine may interfere with the growth and development.

Uses
Glioblastoma multiforme (brain cancer)Persistent, recurrent, or metastatic breast cancerMetastatic cervical cancerAdvanced kidney cancerMetastatic colorectal cancerAdvanced non-small-cell lung cancerLiver Cancer- Hepatocellular carcinomaCancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer

Storage
Store Abevmy 100mg Injection at 2˚C to 8˚C. Do not freeze or shake.

Side Effects
HeadacheVision changesConfusionSevere allergic reactionsHigh Blood pressureDelayed wound healing following surgeryProtein in urineSevere infectionsBlood clots in arteries and blood vessels of lungsGut perforationNosebleeds and bleeding riskHeart problems with an increase in heart rateMouth sores, drynessShortness of breathNumbness in hands or feetWeakness and lack of energyDiarrhoea, nausea, vomiting, abdominal painConstipationLoss of appetiteWeight lossChanges in taste and speechDecrease in counts of white blood cellsFeverDry skinBack pain

Treatment Type	Lung Cancer
Dosage Form	Injection
Packaging Type	Vial
Composition	Ipilimumab
Manufacturer	BDS
Strength	50mg
Country of Origin	Made in India
Brand	Yervoi
Salt Composition	Ipilimumab 50mg
Pack Size	1 Vial 10ml

Yervoi 50mg Injection contains active component as Ipilimumab. This medication is used to treat advanced melanoma (a type of skin cancer) that has spread to other parts of the body. It can treat cancer of the lungs, liver, and kidneys in adults. Also used to treat colorectal cancer in adults and children (12 years and older). Cancer is a disorder in which cells multiply uncontrolled and abnormally. Talk to your physician if you have immune system problems (such as ulcerative colitis, Crohn’s disease, lupus, or sarcoidosis), liver problems, a history of inflammation of the lungs, HIV (human immunodeficiency syndrome) infection, or have had an organ transplant before taking Yervoi 50mg Injection.

Uses
Advanced melanoma (type of skin cancer)Advanced kidney cancerLiver cancerColorectal cancerNon-small cell lung cancer (type of lung cancer)

Storage
Yervoi 50mg Injection should be stored at room temperature between 20-25°C (68-77°F).

Side Effects
Inflammation of the colon (colitis)Inflammation of the liver (hepatitis)Inflammation of the lungs (pneumonitis)Inflammation of the pituitary gland (hypophysitis)Inflammation of the skin (dermatitis)Nerve damage (neuropathy)HypothyroidismAdrenal insufficiencyDiabetesFatigueDiarrheaItchingRashNauseaLoss of appetiteHeadacheInsomniaMuscle painJoint pain

Physical State	Ultra Fluid
Composition	480 mg
Packaging Size	10 ml
Strength	4.8 g /10 ml
Iodine Content	48 %
Dosage Form	Injection
Viscosity	Medium
Packaging Type	Vial
Storage	Store in a cool and dry place away from sunlight
Manufacturer	Guerbet India Pvt Ltd
Salt Composition	ETHYL ESTERS OF IODIZED FATTY ACID OF POPPY SEED OIL-480MG

Lipiodol Ultra Fluid Injection is a diagnostic agent used to improve the contrast in images during radiological exams, helping to visualize better and define specific areas of the body. Radiological examinations use imaging techniques like X-rays, CT scans, MRI, or ultrasound to view the inside of the body for diagnostic purposes.
Lipiodol Ultra Fluid Injection contains ethyl esters of iodized fatty acids derived from poppy seed oil. It enhances tissue visibility by making it appear darker or brighter depending on the test, which helps doctors identify any abnormalities. The iodine content in the medication enhances X-ray absorption, leading to better visualization of body tissues or structures.
In some cases, this medicine may cause side effects like skin redness, rash, itching, hypotension (low blood pressure), runny nose, or eye irritation. The majority of these side effects may not require medical treatment and will subside with time. However, if any of these side effects persist or worsen, consult a doctor.
Lipiodol Ultra Fluid Injection should not be used if you are allergic to it. Inform your doctor about any other medications or herbal products you are taking. Before starting treatment with Lipiodol Ultra Fluid Injection, tell your doctor if you have allergies, asthma, lung or heart diseases, hyperthyroidism, diabetes, uterine bleeding, pelvic inflammation, or kidney disease. Do not use this medicine for hysterosalpingography if you are pregnant, near your menstrual period, or within 30 days after curettage or conization.

Use
• Follow your doctor's instructions on the dosage and timing of this medication.
• Lipiodol Ultra Fluid Injection is administered by the doctor or nurse in a healthcare setting.
• Do not self-administer.

Medicinal Benefits
Lipiodol Ultra Fluid Injection is a diagnostic agent used to improve the contrast in images during radiological exams. It helps by absorbing X-rays, enhancing the contrast between different tissues in the body. It also carries and directs cancer medication to the targeted area for treatment. Lipiodol Ultra Fluid Injection is particularly indicated for use in lymphography (used to visualise the lymphatic system to detect blockages or abnormalities), hysterosalpingography (used to evaluate infertility by examining the uterus and fallopian tubes), and sialography (examination of the salivary glands and ducts for blockages or inflammation).
How Lipiodol Ultra Fluid Injection Works
Lipiodol Ultra Fluid Injection contains ethyl esters of iodized fatty acids derived from poppy seed oil. It enhances tissue visibility by making it appear darker or brighter depending on the test, which helps doctors identify any abnormalities. The iodine content in the medication enhances X-ray absorption, leading to better visualization of body tissues or structures.Storage
Store in a cool and dry place away from sunlight

Strength	100 mg
Dosage Form	Solution for Infusion
Brand	Lupiximab
Storage Temperature	2-8 degree c
Manufacturer	Lupin Ltd.
Shelf Life	24 months
Packaging Type	Vial
Treatment	Chronic Lymphocytic Leukemia
Dose	As per Prescription
Administration Route	Intravenous Infusion
Composition	Rituximab

Lupiximab 100mg injection contains the active constituent rituximab. It is used for several different disease conditions in adults. It is used alone or with other medications to treat non-hodgkin’s lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukemia (a most common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a type of disease where the immune system attacks the body cells of its own joints) in combination with methotrexate in adults. Other uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals).
Lupiximab 100mg injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine, have a weak immune system, or have any severe active infection. Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment. Talk with your doctor if you have ever had a hepatitis B infection because the infection may reactivate again in a few cases and can be severe sometimes. Pregnancy and breastfeeding are not recommended when you are taking this injection.
Common side effects of Lupiximab 100mg injection include infection of the blood, reduced red blood cells, dizziness, swelling in the face and body, itchy skin, diarrhea, increased sweating, and low or high blood pressure. Use effective contraceptives during the treatment and 12 months after the last dose if you can get pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your physician or healthcare professional if you face any infusion reactions, such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.
Uses
Non-hodgkin’s lymphoma (NHL)Chronic lymphocytic leukemia (CLL)Rheumatoid ArthritisGranulomatosis with polyangiitis or microscopic polyangiitisPemphigus vulgaris
Storage
Store Lupiximab 100mg injection in the refrigerator (2°C to 8°C)Do not freezeKeep the injection away from the reach of children and pets.If you have missed any dosing appointments, inform your doctor and schedule immediately.
Side Effects
Swelling in the face and bodyDiarrhea and nauseaItchy skinAnemiaMuscle spasmHeadacheUrinary tract infectionFever, chills, and shiveringInflammation of nasal cavitiesCough, sore throatLoss of hairIncreased or decreased blood pressureChest painHypersensitivity reactionsHepatitis B viral infectionMemory loss, trouble thinking, difficulty in walking

Treatment	Hodgkin Lymphoma
Treatment Type	Breast Cancer
Brand	Cipla
Strength	1 mg
Packaging Type	Vial
Storage Condition	Store Cytoblastine injection in the refrigerator at (2 DegreeC to 8 DegreeC).
Packaging Size	10 ml
Form	Injection
Shelf Life	24 months
Dosage Form	Injection
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cytoblastine injection is an anti-cancer drug belonging to the class of mitotic inhibitors, containing the active ingredient vinblastine. This medication is used in combination with other medicines for the treatment of Hodgkin’s and non-Hodgkin’s lymphoma, testicular cancer, breast cancer, and kaposi’s sarcoma. Hodgkin’s disease and non-Hodgkin’s disease refers to the type of blood cancers. 
This injection should be used with caution in patients with a history of nerve damage, respiratory disease, or gastrointestinal disorders. Special care is needed if you are taking other medicines, as some could interact with this drug. For example the use of erythromycin may increase the side effects of this drug. In case if you are undergoing radiotherapy in the liver area, your doctor will delay giving you this medicine. During the treatment, your doctor may periodically monitor your white blood cell counts, platelets, blood sugar, electrolytes and kidney parameters to prevent serious complications. This medicine has the potential to cause heart problems when combined with other anticancer medicine like bleomycin or cisplatin. Report to your doctor if you experience any hypersensitive reactions like itchy skin or rashes, while taking this medicine.
As there is a risk of birth defects, women of childbearing potential should use effective contraception methods during treatment with this drug. If you're pregnant or breastfeeding women, you may plan to have a baby or think you may be pregnant. Please consult with your doctor for more advice before taking this medicine. Do not drive or use machines if you experience any side effects which may lessen your ability to do so. It is advised not to use this injection if you are allergic to this drug or any of its ingredients, in case you have a bacterial infection which is not under control, and if your blood tests show that you do not have enough WBC to fight infection. This drug may lead to changes in your blood cells, so your doctor will take blood samples to monitor for these and also to check how well your liver is working. Inform to the doctor if you have been diagnosed with liver disorders, heart failure, high blood cholesterol levels, or hypertension before starting this treatment.

Uses
Hodgkin’s lymphomaNon-Hodgkin’s lymphomaTesticular cancerBreast cancerKaposi’s sarcoma


Storage
Store Cytoblastine injection in the refrigerator at (2°C to 8°C).Keep it out of reach from children.

Side Effects 

Severe allergic reactions (difficulty in breathing or swallowing, swelling of hands, feet, lips, mouth, or throat, itchy rash)Swelling or pain at the site of injection (during or immediately after the injection)Low blood countsConvulsionsMental depressionTirednessDiarrheaLoss of appetiteNausea, vomitingStomach crampsHair loss

Formulation Type	Solution
Form of Medicine	Liquid
Brand	Docax
Strength	120 mg
Pack Size	3 ml
Pack Type	Vial
Indication	Breast Cancer
Packaging Size	3 ml
Packaging Type	Vial
Brand Name	Docax
Manufacturer	NEON LABORATORIES LTD
Usages	To treat breast, prostate, non-small cell lung, stomach, and head and neck cancer
Country of Origin	Made in India

Docax 120mg Injection belongs to the class of anticancer medications known as taxoids. It contains the active constituent Docetaxel indicated to treat breast, prostate, non-small cell lung, stomach, and head and neck cancer. Cancer is a disease in which cells multiply in an uncontrolled and abnormal manner. This chemotherapy medication is used alone or in combination with other anticancer medicines.   
The common side effects that are likely to be associated with Docax 120mg Injection are dizziness, headache, fever, infections, loss of appetite, sleeping trouble, joint or muscle pain, eye problems, weight loss, tiredness, dry mouth, reduced blood pressure, hair loss, etc. Inform your doctor if any of these side effects disturb or persist in you. 

Uses
Non-small cell lung cancerBreast cancerStomach or gastric cancerProstate cancerHead and neck cancer

Storage
Do not store above 25°C.

Side Effects
Severe allergic reactionsSevere fluid retentionSevere skin problemsSwelling of the small intestine and colonHeadache, dizzinessFever, infectionsLow blood cell countLoss of appetiteTrouble sleepingJoint or muscle painAlteration in the sense of tasteEye problems, bleeding from the noseNausea, vomitingDiarrhea, constipationAbdominal painHair loss, change in color of your nailsChange or absence of menstrual periodWeight lossTirednessDry mouthHigh blood sugarDecreased blood pressure, rapid heartbeat

Formulation Type	Concentrate
Form of Medicine	Liquid
Brand	Taxotere
Strength	20 mg
Pack Type	Vial
Indication	Breast Cancer
Packaging Size	3 ml
Packaging Type	Vial
Brand Name	Taxotere
Manufacturer	EMCURE PHARMACEUTICALS LTD
Usages	Non-small cell lung cancer Breast cancer Stomach or gastric cancer Prostate cancer Head and neck can
Country of Origin	Made in India

Taxotere 20mg Injection belongs to the class of anticancer medications known as taxoids. It contains the active constituent Docetaxel indicated to treat breast, prostate, non-small cell lung, stomach, and head and neck cancer. Cancer is a disease in which cells multiply in an uncontrolled and abnormal manner. This chemotherapy medication is used alone or in combination with other anticancer medicines.   
The common side effects that are likely to be associated with Taxotere 20mg Injection are dizziness, headache, fever, infections, loss of appetite, sleeping trouble, joint or muscle pain, eye problems, weight loss, tiredness, dry mouth, reduced blood pressure, hair loss, etc. Inform your doctor if any of these side effects disturb or persist in you. 

Uses
Non-small cell lung cancerBreast cancerStomach or gastric cancerProstate cancerHead and neck cancer

Storage
Keep Taxotere 20mg Injection out of sight and reach of children.Do not store above 25°C.

Side Effects
Severe allergic reactionsSevere fluid retentionSevere skin problemsSwelling of the small intestine and colonHeadache, dizzinessFever, infectionsLow blood cell countLoss of appetiteTrouble sleepingJoint or muscle painAlteration in the sense of tasteEye problems, bleeding from the noseNausea, vomitingDiarrhea, constipationAbdominal painHair loss, change in color of your nailsChange or absence of menstrual periodWeight lossTirednessDry mouthHigh blood sugarDecreased blood pressure, rapid heartbeat

Strength	100 mg/5 ml
Vial Volume	5 ml
Brand	Campto
Packaging Size	5 ml Vial
Composition	Irinotecan 100 mg
Route of Administration	IV Infusion
Indication	Colorectal Cancer
Storage Condition	Store protected from light at a temperature not exceeding 25 DegreeC.
Prescription/Non prescription	Prescription
Form	Injection
Country of Origin	Made in India

Campto 100mg Injection belongs to the group of medications called anti-cancer medicines or cytostatics. It consists of the active ingredient Irinotecan hydrochloride trihydrate. It is indicated for advanced colon cancer and rectal cancer in adults. It is prescribed alone or in combination with other chemotherapeutic agents. Cancer in the colon and rectum is prevalent in age groups above 50 and is further triggered by genetic and environmental factors.

Uses
Treatment of metastatic cancer of the colon and rectum (large intestine).

Storage 
Do not freeze.Store protected from light at a temperature not exceeding 25°C.

Side Effects
Early and late diarrheaAllergic reactionsKidney impairmentLung problemsLow levels of RBC, WBC, and platelets in the bloodNausea, vomiting, abdominal painConstipationDiarrheaAnemiaPainFatigueFever, infections including sepsisAbnormal bilirubin levelsHair lossWeight loss

Strength	100 mg
Dosage Form	Solution for Infusion
Brand	Veltiro
Storage Temperature	2-8 degree c
Manufacturer	Zydus Cadila
Shelf Life	24 months
Packaging Type	Vial
Treatment	Non-Hodgkin Lymphoma
Dose	As per Prescription
Administration Route	IV
Composition	Rituximab

Veltiro 100mg injection contains the active constituent rituximab. It is used for several different disease conditions in adults. It is used alone or with other medications to treat non-hodgkin’s lymphoma (cancer affecting white blood cells called B-lymphocytes) and chronic lymphocytic leukemia (a most common form of cancer that affects B-cells). It is also indicated to treat moderate-to-severe rheumatoid arthritis (a type of disease where the immune system attacks the body cells of its own joints)  in combination with methotrexate in adults. Other uses include granulomatosis with polyangiitis or microscopic polyangiitis (inflammation of blood vessels that mainly affects the lungs and kidneys) in adults and children 2 years of age and older. It is also used to treat moderate to severe pemphigus vulgaris (an autoimmune condition that causes painful blisters on the skin and lining of the mouth, throat, nose, and genitals).
Veltiro 100mg injection belongs to the class of medications called anti-CD20 monoclonal antibodies. Do not take this injection if you are allergic to rituximab or any other ingredients of this medicine, have a weak immune system, or have any severe active infection. Inform your physician if you have heart disease, heart failure, or breathing problems before initiating the treatment. Talk with your doctor if you have ever had a hepatitis B infection because the infection may reactivate again in a few cases and can be severe sometimes. Pregnancy and breastfeeding are not recommended when you are taking this injection.
Common side effects of Veltiro 100mg injection include infection of the blood, reduced red blood cells, dizziness, swelling in the face and body, itchy skin, diarrhea, increased sweating, and low or high blood pressure. Use effective contraceptives during the treatment and 12 months after the last dose if you can get pregnant. This medicine may cause severe infusion reactions during or within 24 hours after administration. Inform your physician or healthcare professional if you face any infusion reactions, such as increased blood pressure, chest pain, headache, breathing difficulties, vomiting, skin rashes, or throat swelling.

Uses
Non-hodgkin’s lymphoma (NHL)Chronic lymphocytic leukemia (CLL)Rheumatoid ArthritisGranulomatosis with polyangiitis or microscopic polyangiitisPemphigus vulgaris

Storage
Store Veltiro 100mg injection  in the refrigerator (2°C to 8°C)Do not freezeKeep the injection away from the reach of children and pets.If you have missed any dosing appointments, inform your doctor and schedule immediately.

Side Effects
Swelling in the face and bodyDiarrhea and nauseaItchy skinAnemiaMuscle spasmHeadacheUrinary tract infectionFever, chills, and shiveringInflammation of nasal cavitiesCough, sore throatLoss of hairIncreased or decreased blood pressureChest painHypersensitivity reactionsHepatitis B viral infectionMemory loss, trouble thinking, difficulty in walking

Standard	BP
Dosage Form	Solution
Brand	Celocarb
Packaging Type	Vial
Pack Size	45 ml
Pack Type	Vial
Treatment	Ovarian Cancer
Manufacturer	CELON LABORATORIES LTD
Strength	450 mg/45ml
Brand Name	Celcarb
Usages	To treat certain types of cancer
Shelf Life	24 Months
Country of Origin	Made in India

Celcarb 450mg injection belongs to the medication class known as an alkylating agent. It is an anti-cancer medicine that contains the active ingredient Carboplatin. It treats a certain type of ovarian and lung cancer as a single or combined with other medications. 
Consult your doctor if you have any symptoms of allergic reactions, abnormal bruises, kidney problems (haemolytic-uraemic syndrome), and a decrease in red blood cells (anemia). Report to your doctor if you experience any lung-related symptoms like; shortness of breath, lung tissue inflammation, or lung infection while taking a Celcarb 450mg injection. 

Uses
Celcarb 450mg injection treats ovarian and lung cancer.

Storage
Keep away from the reach of children.Protect the tablets from light and metal; store them below 25°C.Do not refrigerate the injection.

Side Effects
Reduced number of red blood cells (anemia)Allergic reactionsAbnormal bruisesKidney problemsHearing problemsFever, chillsLoss of taste, diarrheaConstipationHair lossSkin rashesItchinessExtreme tiredness and weaknessInflammation in lung tissuesTingling or numbness in your hands, arms, or legsPrickling sensationDifficulties in breathing

Formulation Type	Solution
Form of Medicine	Liquid
Brand	Docetax
Strength	20 mg
Pack Size	3 ml
Pack Type	Vial
Indication	Prostate Cancer
Packaging Size	3 ml
Packaging Type	Vial
Brand Name	Docetax
Manufacturer	CIPLA LTD
Usages	It is a chemotherapy medication used to treat breast, prostate, non-small cell lung, stomach, and he
Country of Origin	Made in India

Docetax 120mg Injection contains an active constituent of docetaxel, which belongs to the class of anticancer medications known as taxoids. It is a chemotherapy medication used to treat breast, prostate, non-small cell lung, stomach, and head and neck cancers. This chemotherapy medication is used alone or in combination with other anticancer medicines.

Uses
Non-small cell lung cancerBreast cancerStomach or gastric cancerProstate cancerHead and neck cancer

Storage
Do not store above 25°C.Do not use this medicine after the expiry date.

Side Effects
Severe allergic reactionsSevere fluid retentionSevere skin problemsSwelling of the small intestine and colonHeadache, dizzinessRisk of infectionsLow blood cell countLoss of appetiteTrouble sleepingJoint or muscle painAlteration in the sense of tasteEye problems, bleeding from the noseNausea, vomitingDiarrhea, constipationAbdominal painHair loss, change in color of your nailsChange or absence of menstrual periodWeight lossTirednessDry mouthHigh blood sugarDecreased blood pressure, rapid heartbeat

Dosage Form	Injection
Strength	500 mg
Treatment	Non-Small Cell Lung Cancer
Packaging Type	Vial
Pack Type	Vial
Manufacturer	Esperer Bioresearch Pvt Ltd
Brand Name	Es Peme
Pharmacopoeia Standard	IP
Usages	Non-small cell lung cancer and Malignant pleural mesothelioma
Country of Origin	Made in India

Es Peme 500 Injection is used in the treatment of non-small cell lung cancer and malignant pleural mesothelioma.
Es Peme 500 Injection is given as an injection by a qualified medical professional. Your doctor will decide what dose is necessary and how often you need to take it. This will depend on what you are being treated for and may change from time to time. You should take it exactly as your doctor has advised. Taking it in the wrong way or taking too much can cause very serious side effects. It may take several weeks or months for you to see or feel the benefits but do not stop taking it unless your doctor tells you to.
The most common side effects of this medicine include nausea, vomiting, loss of appetite, and hair loss. This medicine may reduce the number of blood cells (decrease red blood and white blood cells) in your blood, thereby, increasing the susceptibility to infections. Regular blood tests are required to check your blood cells along with heart, liver and blood uric acid levels.
Before taking it, tell your doctor if have heart disease, liver, or kidney problems or are taking any medicines to treat infections. Many other medicines can affect, or be affected by, this medicine so let your doctor know all medications you are using.This medicine is not recommended during pregnancy or while breastfeeding. Use of effective contraception by both males and females during treatment is important to avoid pregnancy.

Uses
Non-small cell lung cancerMalignant pleural mesothelioma

Storage
Store in a refrigerator (2 - 8°C). Do not freeze.

Side Effects
NauseaVomitingSore throatLoss of appetiteStomatitis (Inflammation of the mouth)Hair lossLow blood plateletsRashFatigueAnemia (low number of red blood cells)DiarrheaDecreased white blood cell count (neutrophils)Neuropathy

Strength	150 mg
Packaging Type	Vial
Brand Name	Neuzumab
Manufactured By	LUPIN LTD
Usage	Hospital
Shelf Life	24 months

Neuzumab 150mg Injection consists of Trastuzumab as an active constituent which is indicated for its use in HER 2 breast cancer. In HER 2 positive patients, the breast cancer cells are mostly composed of HER2 proteins that cause rapid development of cancer tumor by serving as a signal to the cancerous. This medication is also used to treat metastatic gastric cancer with increased levels of HER2 proteins.
Her 2 positive breast cancer are most aggressive in nature. The targeted therapy for her 2 positive breast cancer works by selectively targeting the proteins that are responsible for the growth, development, and spread of cancer. Use effective birth control during the treatment and for at least 7 months after the final dose.

Uses
Advanced and metastatic breast cancerMetastatic gastric cancer

Storage
Store between 2˚C and 8˚C.

Side Effects
Heart ProblemsAllergic reactionsKidney problemsBreathing difficultiesFeverVisual disturbancesNose bleeds or runny noseHair lossDizzinessNail disordersWeight lossLoss of appetiteBruisingDry mouthLiver  inflammationMuscle painAsthma/ lung disorders

Packaging Type	Vial
Country of Origin	Made in India
Brand	Abevmy
Manufacturer	MYLAN PHARMACEUTICALS PVT LTD
Strength	Bevacizumab 400mg
Pack size	1's
Expiry	24 months

Abevmy 400mg Injection is an anticancer medicine consisting of the active ingredient Bevacizumab. This medicine is developed to prevent the growth of tumors. It is indicated along with other chemotherapy drugs to treat metastatic breast cancer, brain cancer, cervical cancer, kidney cancer, lung cancer, and colorectal cancer. It is also used to treat cancers of the ovary, fallopian tube or primary peritoneal cancer. Use effective birth control during the treatment and for at least six months after the last dose. Abevmy 400mg Injection is not recommended for adolescents and children under the age of 18. Discuss with your doctor about the preservation of ovaries if you are planning for pregnancy in the near future as this medicine may cause fertility issues in women. It would be best to avoid breastfeeding your baby as this medicine may interfere with the growth and development.

Uses
Glioblastoma multiforme (brain cancer)Persistent, recurrent, or metastatic breast cancerMetastatic cervical cancerAdvanced kidney cancerMetastatic colorectal cancerAdvanced non-small-cell lung cancerLiver Cancer- Hepatocellular carcinomaCancers of the ovary, cervical, fallopian tube, or primary peritoneal cancer

Storage
Store Abevmy 400mg Injection at 2˚C to 8˚C. Do not freeze or shake.

Side Effects
HeadacheVision changesConfusionSevere allergic reactionsHigh Blood pressureDelayed wound healing following surgeryProtein in urineSevere infectionsBlood clots in arteries and blood vessels of lungsGut perforationNosebleeds and bleeding riskHeart problems with an increase in heart rateMouth sores, drynessShortness of breathNumbness in hands or feetWeakness and lack of energyDiarrhoea, nausea, vomiting, abdominal painConstipationLoss of appetiteWeight lossChanges in taste and speechDecrease in counts of white blood cellsFeverDry skinBack pain

Dosage Form	Injectable Solution
Route Of Administration	Intravenous
Brand	Alkacel
Packaging Type	Vial
Strength	50 mg/vial
Packaging Size	Single Vial dose
Treatment	Multiple Myeloma
Presciption/Non Prescription	Presciption
Usage	To treat multiple myeloma
Manufacturer	CELON LABORATORIES LTD
Country of Origin	Made in India

Alkacel 50mg injection contains the active constituent Melphalan. It is an anticancer agent that belongs to the class of medications called alkylating agents. It is used to treat multiple myeloma (a type of cancer of the bone marrow). It is also used to treat advanced ovarian cancer. It is also indicated to treat childhood neuroblastoma (cancer of the nervous system), malignant melanoma (skin cancer), and soft tissue sarcoma (cancer of the muscle, fat, fibrous tissue, blood vessels, or other supporting tissues of the body). It works by reducing the number of abnormal cells your body makes.

UsesMultiple myelomaAdvanced ovarian cancerChildhood neuroblastomaMalignant melanomaSoft tissue sarcoma

Storage
Store in a refrigerator, 2° to 8°CProtect the medicine from light and excessive moisture.Keep the medicine out of reach of children and petsIf you missed the dosing schedule, inform your healthcare professional immediately and reschedule.

Decreased blood cell countNausea, vomiting, diarrheaMouth ulcersHair lossCardiac arrestLiver inflammationHypersensitivity skin reactionsAcute renal failureLung inflammation

Strength	10 mg
Treatment Type	Breast Cancer
Vial Volume	20 ml
Dosage Form	Injection
Brand	Cipla
Packaging Type	Vial
Concentration	1 mg/ml
Form	Injection
Route	IV
Storage Condition	Store at 25 degree Celsius
Prescription/Non prescription	Prescription
Country of Origin	Made in India

Cytoplatin 10mg injection belongs to the medication class known as an alkylating agent. It is an antineoplastics medicine that contains the active ingredient Cisplatin. It treats a certain type of cancer, such as testicular, ovarian, bladder, lung, cervical, head, and neck epithelial tumor, as a single or combined with radiotherapy. If you are allergic to this drug or its ingredients, tell your doctor before starting treatment with this medication. Notice your doctor if you have hypersensitivity, myelosuppression (lower number of blood cells), or hearing difficulties. This medicine should not be taken if you have recently been vaccinated with a live vaccine, including yellow fever. So, inform your doctor if you are planning to have one. 
Inform your doctor if you have any symptoms of nerve damage (peripheral neuropathy) and if you have had any radiotherapy to the head. This medicine may cause problems with your kidney, liver, and blood.  So, your doctor may perform blood tests regularly to monitor your blood, kidney, and liver function. Both men and women are recommended to use effective contraception while receiving this medication and continue to use it for six months, even after receiving the final dose. This medicine may reduce fertility permanently in men. So it is advised to get suggestions about fertility concerns from your doctor.

Uses
Testicular tumorOvarian tumorBladder tumorLung cancerHead and neck epithelial tumorCervical cancer

Storage
Store at a temperature below 25˚C. Do not refrigerate.Keep the vials away from direct sunlight.Keep this medicine out of sight and reach of children.

Side Effects 
Allergic reactionsNeuropathyKidney problemsSevere chest painPain or swelling at the site of injectionConfusion, slurry speech, paralysisStrokeBlood clots in veinFast, irregular or slow heartbeatsSepsisDecrease in bone marrow functionDecrease in the number of WBC, RBC, Platelets (thrombocytopenia) sodium in bloodHigh temperatureVomiting

Treatment Type	Breast Cancer
Vial Volume	50 ml
Dosage Form	Injection
Brand	Cytoplatin
Strength	50mg
Concentration	1 mg/ml
Composition	Cisplatin
Form	Injection
Route	IV Infusion
Manufacturer	Cipla Ltd
Packaging Size	1 unit
Storage	25 degree c
Packing Type	Vial
Shelf Life	24 months

Cytoplatin 50mg injection belongs to the medication class known as an alkylating agent. It is an antineoplastics medicine that contains the active ingredient Cisplatin. It treats a certain type of cancer, such as testicular, ovarian, bladder, lung, cervical, head, and neck epithelial tumor, as a single or combined with radiotherapy. If you are allergic to this drug or its ingredients, tell your doctor before starting treatment with this medication. Notice your doctor if you have hypersensitivity, myelosuppression (lower number of blood cells), or hearing difficulties. This medicine should not be taken if you have recently been vaccinated with a live vaccine, including yellow fever. So, inform your doctor if you are planning to have one. 
Inform your doctor if you have any symptoms of nerve damage (peripheral neuropathy) and if you have had any radiotherapy to the head. This medicine may cause problems with your kidney, liver, and blood.  So, your doctor may perform blood tests regularly to monitor your blood, kidney, and liver function. Both men and women are recommended to use effective contraception while receiving this medication and continue to use it for six months, even after receiving the final dose. This medicine may reduce fertility permanently in men. So it is advised to get suggestions about fertility concerns from your doctor.

Uses
Testicular tumorOvarian tumorBladder tumorLung cancerHead and neck epithelial tumorCervical cancer

Storage
Store at a temperature below 25˚C. Do not refrigerate.Keep the vials away from direct sunlight.Keep this medicine out of sight and reach of children.

Side Effects 
Allergic reactionsNeuropathyKidney problemsSevere chest painPain or swelling at the site of injectionConfusion, slurry speech, paralysisStrokeBlood clots in veinFast, irregular or slow heartbeatsSepsisDecrease in bone marrow functionDecrease in the number of WBC, RBC, Platelets (thrombocytopenia) sodium in bloodHigh temperatureVomiting

Strength	50 mg
Vial Volume	ml
Strength per ml	5 mg/ml
Packaging Type	Vial
Composition	Epirubicin Hydrochloride
Brand	Erubin
Manufacturer	RPG LIFE SCIENCES LTD
Usage / Application	Hospital
Storage Conditions	Store erubin 50mg injection in the refrigerator (2 DegreeC to 8 DegreeC) Do not freeze
Shelf Life	24 months

Erubin 50mg injection contains the active substance epirubicin hydrochloride. It is an antineoplastic drug that belongs to the class anthracyclines. This medicine is used as adjuvant therapy in combination with other medications to treat breast cancer in patients who have had surgery to remove the tumor. It is also found useful in treating cancers of the breast, ovaries, stomach, bowel, and lung. In addition, this medicine is also used to treat cancers of the blood-forming tissues, such as malignant lymphomas, leukemias, and multiple myeloma.
Do not take this injection if you are allergic to epirubicin or any other ingredients of this medicine, pregnant or breastfeeding, or have severe liver and bladder problems. Before initiating the treatment, inform your physician if you have kidney or liver problems, recent vaccination, or if you have any acute toxicities such as acute inflammation of the mouth, low white blood cell count, platelet count, or any infections. This medicine may increase your risk of blood clots.

Uses
Breast cancerStomach and bowel cancerOvarian cancerLung cancer

Storage
Store erubin 50mg injection in the refrigerator (2°C to 8°C)Do not freeze

Side Effects
Hair lossFlushingRash, itchingDiarrheaNausea and vomitingAnemiaDecreased WBC and plateletsEye infectionIrregular menstruationCongestive heart failureIncreased blood urea levelsSevere hypersensitivity reactionLung problems

Strength	1 g
Injection Type	Solution
Brand	Cycloxan
Composition	Cyclophosphamide IP
Packaging Size	Vial
Storage Condition	Keep out of sight and reach of children. Store vials below or at 25 DegreeC.
Prescription/Non prescription	Prescription
Form	Injection
Packaging type	Bottle
Country of Origin	Made in India

Cycloxan 1gm Injection is a chemotherapy drug containing the active constituent cyclophosphamide. It is used to treat various malignancies (abnormal production of cells is called cancer, and if they spread to other organs then they are called malignancies). Cycloxan 1gm Injection can be used to treat malignant lymphomas (cancers that start from the lymphatic system of the body- vessels, fluid, and lymphoid tissue) such as Hodgkin’s disease, lymphocytic lymphoma, and mixed-cell type lymphoma. 
It is used to treat leukemias, neuroblastoma, ovarian cancer, retinoblastoma, and breast carcinoma. It can also treat Minimal Change Nephrotic syndrome in pediatric patients (kidney disease in which large quantities of protein are lost in urine). Cycloxan 1gm Injection is contraindicated in pregnancy, patients with acute infections, urinary tract infections, urinary outflow obstruction, and bone marrow disorders.  
Treatment with this medicine may lead to immune suppression, bone marrow failure, cardiotoxicity, renal toxicity, pulmonary toxicity, and secondary malignancies. Inform your doctor if you have pre-existing kidney disease, immune conditions, cardiac disorders, or liver diseases.

Uses
Malignant lymphomasLeukemiasRetinoblastomaCarcinoma of breastOvarian cancerMycosis fungoidesMinimal Change Nephrotic Syndrome in Pediatric Patients

Storage
Keep out of sight and reach of children. Store vials below or at 25°C.

Side Effects 
InfectionsImmune suppressionBlood disordersAllergic reactionsAbnormal liver functionInflammation of the bladderKidney diseasesblood in urinesterilityimpaired wound healingNausea, vomitingLow white blood cell countDiarrheaHair lossFeverWeaknessInflammationDizzinessBlurred visionamenorrhea

Strength	200 mg
Brand	Dacarbazine
Pharmacopoeia Standard	USP
Packaging Type	Vial
Pack Type	Vial
Packaging Size	1 Vial
Route Of Administration	Intravenous
Physical Form	Lyophilized Powder
Brand Name	Decarb
Manufacturer	CIPLA LTD
Usages	To treat various types of cancer
Country of Origin	Made in India

Decarb 200mg injection is an antineoplastic drug belonging to the class of alkylating agents, containing the active ingredient Dacarbazine. It is used to prevent and treat metastatic malignant melanoma (skin cancer), Hodgkin's disease (cancer that forms in the lymph system, part of the immune system).
It is often combined with cisplatin, a cytotoxic agent, to treat certain types of cancers for the treatment of Hodgkin's lymphoma, and also combined with temozolomide for the treatment of melanoma. There may be an increased risk of certain types of skin cancer (non-melanoma skin cancer) with the use of this medicine. This drug is contraindicated in pregnant women, and women of childbearing potential should use effective contraception during and for at least 6 months after treatment with the drug. It is not known whether it is excreted in human milk, so breastfeeding should be avoided during treatment with the drug. It should also be used with caution in patients with pre-existing liver or kidney dysfunction. You should not have a live vaccine if you are having this injection. This is because it may weaken your immune system and make you more likely to catch a serious infection. Consult your doctor immediately for more advice.

Uses
Metastatic malignant melanomaHodgkin’s disease

Storage
Store Decarb 200mg injection in the refrigerator (2°-8°C). Do not freeze.

Side Effects
Sore throat or high temperature indicating infectionUnusual bleeding or bruisingSevere vomiting or diarrheaExtreme tirednessSevere allergic reaction, characterized by swelling of hands, feet, ankles, face, lips, mouth or throat; rashes or giddiness.Headache, vision problems, fits, confusion, lethargy or numbness of faceSevere liver problemsLow levels of RBC, WBC and platelets in blood.Loss of appetiteNausea, vomitingHair lossSkin reactions

Strength	500 mg
Brand	Decarb
Pharmacopoeia Standard	USP
Packaging Type	Vial
Pack Type	Vial
Packaging Size	1 Vial
Route Of Administration	Intravenous
Physical Form	Solution
Brand Name	Decarb
Manufacturer	CIPLA LTD
Usages	To treat various types of cancer
Country of Origin	Made in India

Decarb 500mg injection is an antineoplastic drug belonging to the class of alkylating agents, containing the active ingredient Dacarbazine. It is used to prevent and treat metastatic malignant melanoma (skin cancer), Hodgkin's disease (cancer that forms in the lymph system, part of the immune system).
It is often combined with cisplatin, a cytotoxic agent, to treat certain types of cancers for the treatment of Hodgkin's lymphoma, and also combined with temozolomide for the treatment of melanoma. There may be an increased risk of certain types of skin cancer (non-melanoma skin cancer) with the use of this medicine. This drug is contraindicated in pregnant women, and women of childbearing potential should use effective contraception during and for at least 6 months after treatment with the drug. It is not known whether it is excreted in human milk, so breastfeeding should be avoided during treatment with the drug. It should also be used with caution in patients with pre-existing liver or kidney dysfunction. You should not have a live vaccine if you are having this injection. This is because it may weaken your immune system and make you more likely to catch a serious infection. Consult your doctor immediately for more advice.

Uses
Metastatic malignant melanomaHodgkin’s disease

Storage
Store Decarb 500mg injection in the refrigerator (2°-8°C). Do not freeze.

Side Effects
Sore throat or high temperature indicating infectionUnusual bleeding or bruisingSevere vomiting or diarrheaExtreme tirednessSevere allergic reaction, characterized by swelling of hands, feet, ankles, face, lips, mouth or throat; rashes or giddiness.Headache, vision problems, fits, confusion, lethargy or numbness of faceSevere liver problemsLow levels of RBC, WBC and platelets in blood.Loss of appetiteNausea, vomitingHair lossSkin reactions

Strength	200 mg
Brand	Celdaz
Pharmacopoeia Standard	IP
Pack Size	2 ml
Pack Type	Vial
Packaging Size	1 Vial
Route Of Administration	Intravenous
Physical Form	Lyophilized Powder
Brand Name	Celdaz
Manufacturer	CELON LABORATORIES LTD
Usages	To treat various types of cancer
Country of Origin	Made in India

Celdaz 200mg injection is an antineoplastic drug belonging to the class of alkylating agents, containing the active ingredient Dacarbazine. It is used to prevent and treat metastatic malignant melanoma (skin cancer), Hodgkin's disease (cancer that forms in the lymph system, part of the immune system).
It is often combined with cisplatin, a cytotoxic agent, to treat certain types of cancers for the treatment of Hodgkin's lymphoma, and also combined with temozolomide for the treatment of melanoma. There may be an increased risk of certain types of skin cancer (non-melanoma skin cancer) with the use of this medicine. This drug is contraindicated in pregnant women, and women of childbearing potential should use effective contraception during and for at least 6 months after treatment with the drug. It is not known whether it is excreted in human milk, so breastfeeding should be avoided during treatment with the drug. It should also be used with caution in patients with pre-existing liver or kidney dysfunction. You should not have a live vaccine if you are having this injection. This is because it may weaken your immune system and make you more likely to catch a serious infection. Consult your doctor immediately for more advice.

Uses
Metastatic malignant melanomaHodgkin’s disease

Storage
Store Celdaz 200mg injection in the refrigerator (2°-8°C). Do not freeze.

Side Effects
Sore throat or high temperature indicating infectionUnusual bleeding or bruisingSevere vomiting or diarrheaExtreme tirednessSevere allergic reaction, characterized by swelling of hands, feet, ankles, face, lips, mouth or throat; rashes or giddiness.Headache, vision problems, fits, confusion, lethargy or numbness of faceSevere liver problemsLow levels of RBC, WBC and platelets in blood.Loss of appetiteNausea, vomitingHair lossSkin reactions

Strength	1 g
Injection Type	Solution
Brand	Endoxan
Composition	Cyclophosphamide IP
Packaging Size	1 Vial
Storage Condition	Store vials below or at 25 DegreeC.
Prescription/Non prescription	Prescription
Form	Injection
Packaging type	Bottle
Country of Origin	Made in India

Endoxan N 1gm Injection is a chemotherapy drug containing the active constituent cyclophosphamide. It is used to treat various malignancies (abnormal production of cells is called cancer, and if they spread to other organs, they are called malignancies). Endoxan N 1gm Injection can be used to treat malignant lymphomas (cancers that start from the lymphatic system of the body- vessels, fluid, and lymphoid tissue) such as Hodgkin’s disease, lymphocytic lymphoma, and mixed-cell type lymphoma. 
It is used to treat leukemias, neuroblastoma, ovarian cancer, retinoblastoma, and breast carcinoma. It can also treat Minimal Change Nephrotic syndrome in pediatric patients (kidney disease in which large quantities of protein are lost in urine). Endoxan N 1gm Injection is contraindicated in pregnancy, patients with acute infections, urinary tract infections, urinary outflow obstruction, and bone marrow disorders.

Uses
Malignant lymphomasLeukemiasRetinoblastomaCarcinoma of breastOvarian cancerMycosis fungoidesMinimal Change Nephrotic Syndrome in Pediatric Patients

Storage
Store vials below or at 25°C.

Side Effects
InfectionsImmune suppressionBlood disordersAllergic reactionsAbnormal liver functionInflammation of the bladderKidney diseasesBlood in urineSterilityImpaired wound healingNausea, vomitingLow white blood cell countDiarrheaHair lossFeverWeaknessInflammationDizzinessBlurred visionAmenorrhea